Migraine Resources
Your Go-To While On the Go
Find all the information you need about treating your migraine attacks
Find all the information you need about treating your migraine attacks
Find all of the information you need about treating your migraine attacks anytime, anywhere with UBRELVY®.
There are many options when it comes to working with a healthcare provider to discuss a UBRELVY prescription. Find the one who best fits your needs and can deliver the level of care you're looking for. You can visit:
- A primary care physician with a broad knowledge of migraine. If you've been seeing one for other reasons, they will know your medical history already.
- A nurse practitioner or physician assistant who specializes in headache medicine to get a clinical evaluation, diagnosis, and necessary prescriptions.
- A neurologist who specializes in treating headaches will have a deep knowledge of migraine and be up to date on current treatment options including UBRELVY.
- A headache center is ideal for more complex cases because multiple doctors from various disciplines come together to provide treatment. Your team may consist of a neurologist, psychologist, physical therapist, and even a nutritionist.
Once you choose which provider is right for you, get started by downloading and printing this doctor discussion guide and reach out to a doctor using the tips below.
Use telemedicine to connect to a doctor, here’s how:
Answer a few simple questions.
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
If a prescription is written, you can pick it up at a local pharmacy you choose.
UpScript§, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
§Third-party website; does not constitute an endorsement or recommendation by AbbVie.
Find a doctor in your area, here’s how:
Use the directory to find a healthcare provider in your area who may be able to help.
Make an appointment with the healthcare provider that best suits your needs.
Fill out and bring this conversation starter to discuss what's working or not working with your current treatment plan.
UpScript§, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
§Third-party website; does not constitute an endorsement or recommendation by AbbVie.
It’s important to keep UBRELVY on hand, but here are a few important tips to keep in mind if you live with migraine. Follow UBRELVY on Instagram for more helpful content.
KNOW YOUR MIGRAINE.
BEING AWARE OF THE SIGNS AND SYMPTOMS OF MIGRAINE, LIKE LIGHT AND SOUND SENSITIVITY, CAN HELP YOU TRACK YOUR OWN MIGRAINE CAUSES AND STEER CLEAR OF THEM.
AVOID COMMON MIGRAINE TRIGGERS.
STRESS, LACK OF SLEEP, CAFFEINE, AND STRONG SMELLS CAN ALL TRIGGER MIGRAINE, SO TRY TO KEEP A CONSISTENT ROUTINE.
TAKE MIGRAINE OFF THE MENU.
SOME FOODS CAN TRIGGER MIGRAINE ATTACKS. TRY AVOIDING PRESERVATIVES, INGREDIENTS ADDED FOR FLAVOR, AND NITRATES FOUND IN CURED AND PROCESSED MEATS.
Know your migraine.
Being aware of the signs and symptoms of migraine, like light and sound sensitivity, can help you track your own migraine causes and steer clear of them.
Avoid common migraine triggers.
Stress, lack of sleep, caffeine, and strong smells can all trigger migraine, so try to keep a consistent routine
Take migraine off the menu.
Some foods can trigger migraine attacks. Try avoiding preservatives, ingredients added for flavor, and nitrates found in cured and processed meats.
Talk to one of our live representatives who can answer your questions about insurance coverage, cost, and other topics related to UBRELVY.
Call UBRELVY Complete:
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.
Get more information about UBRELVY from our comprehensive brochure.
Get more information about UBRELVY from our comprehensive brochure.
Talk to one of our live representatives who can answer your questions about insurance coverage, cost, and other questions you may have about UBRELVY.
Call UBRELVY Complete:
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.
Mission: To mobilize a community for patient support and advocacy as well as drive and support impactful research that translates into advances for patients with migraine and other disabling diseases that cause severe head pain.
Mission: To expand the understanding of migraine and its true scope by supporting research, education, and awareness.
Mission: To cure headache and to end its pain and suffering.
Mission: To cure headache and to end its pain and suffering.
Mission: To expand the understanding of migraine and its true scope by supporting research, education, and awareness.
Mission: To help people with headache diseases by providing information, resources, events, community, and advocacy. CHAMP brings together organizations and leaders in this disease area to enhance communication, coordination, and collaboration.
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including allergic reactions. Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
US-UBR-230118
Please see full Patient Information.
For questions, call
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.
For questions, call
1.844.4.UBRELVY (1.844.482.7358),
Monday–Friday, 8:00 am to 8:00 pm Eastern Time.
Use telemedicine to connect to a doctor. Here's how:
Answer a few simple questions about your migraine attacks and current treatment plan.
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
If a prescription is written, you can pick it up at a local pharmacy you choose.
AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.
*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.
By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.
By clicking “Continue” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the American Migraine Foundation (“AMF”), a division of the American Headache Society®, any healthcare provider (“HCP”), or the qualifications of any HCP associated with AMF, or the quality of medical care any of those HCPs can provide. Further, you also acknowledge and agree that AbbVie makes no guarantees that using AMF will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential HCP. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential HCP. ABBVIE AND ITS AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE AMF WEBSITE. Please be aware of that AMF may have its own set of terms and conditions and privacy policy for which AbbVie has no responsibility.
If you agree to the above, click “Continue” to proceed to the AMF website. If you do not agree to the above, click “Cancel” to remain on the current website.
Use telemedicine to connect to a doctor. Here's how:
Answer a few simple questions about your migraine attacks and current treatment plan.
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
If a prescription is written, you can pick it up at a local pharmacy you choose.
AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.
*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.
By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.
Important Updates to the Patient Information for UBRELVY® (ubrogepant) tablets1
On February 17, 2023, the UBRELVY (ubrogepant) Prescribing Information and Patient Information were updated to include new information about serious allergic reactions.
The following describes the recent changes to the UBRELVY Patient Information:
The following serious allergic reactions information was added:
Who should not use UBRELVY?
Do not take UBRELVY if you are:
What are the possible side effects of UBRELVY?
UBRELVY may cause serious side effects, including:
This is not a complete list of all the changes made to the Prescribing Information and Patient Information for UBRELVY. Please refer to the full Prescribing Information and Patient Information for additional safety information.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
IMPORTANT SAFETY INFORMATION
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including allergic reactions. Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help.
Visit AbbVie.com/myAbbVieAssist to learn more.
Please see accompanying Patient Information or visit
www.rxabbvie.com/pdf/ubrelvy_pil.pdf
Reference: 1. UBRELVY [package insert]. Madison, NJ: Allergan USA, Inc.
© 2023 AbbVie. All rights reserved. US-UBR-230012 February 2023
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, itraconazole.
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including allergic reactions. Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/myAbbVieAssist to learn more.
US-UBR-230118